Corning and DSM Announce Successful Pilot Operation of Industrial-Scale Microreactor for cGMP Pharmaceutical Production
CORNING, N.Y., Oct 01, 2008 (BUSINESS WIRE) -- Corning Incorporated (NYSE:GLW) and DSM Pharma Chemicals announced
publication of a joint paper at CPhI Worldwide 2008 in Frankfurt,
Germany this week, describing a successful, commercially viable
demonstration of Corning's microreactor
technology for Current Good Manufacturing Practice (cGMP) production.
Working together, teams from the two companies demonstrated a reliable,
industrial-scale operation of a hazardous nitration reaction under cGMP
conditions, processing more than 25 metric tons of material in only four
weeks. Corning's microreactor technology
demonstrated high reliability and quality, showing capability to handle
800 metric tons of process fluids per year, assuming 8,000 hours of
continuous operation.
"Low-throughput microreactors and
lab-on-a-chip type technologies have been around for many years, but for
the first time we have been able to show how Corning's
unique microreactor technology can solve an existing problem by
demonstrating efficient processing at an industrial scale with a
difficult chemical reaction," says Dr. Gary
Calabrese, vice president, Science and Technology, Corning Incorporated. "Effective
mixing, heat transfer, corrosion resistance and other attributes of
Corning's technology provide a unique and
powerful solution to this challenge and many other chemistries."
Corning's proprietary microreactor processing
technology is compact, adaptable and scalable, optimizing the cost of
manufacturing and overall quality of high-value specialty, fine and
pharmaceutical chemicals. This technology, paired with Corning's
design and engineering expertise, provides customers with a customized
reactor solution to meet their unique chemistry needs.
"Through the outstanding effort of an
intercompany team from Corning and DSM, a pilot production introducing a
new technology for a challenging reaction could be realized in a
remarkably short period of time," said Dr.
Bernt Schober, new business development operations manager, DSM Pharma
Chemicals. "The combination of Corning's
microreactor technology and DSM's chemical
expertise allowed us to carry out this pilot production in a safe and
operationally effective way."
About Corning Incorporated
Corning Incorporated (www.corning.com)
is the world leader in specialty glass and ceramics. Drawing on more
than 150 years of materials science and process engineering knowledge,
Corning creates and makes keystone components that enable
high-technology systems for consumer electronics, mobile emissions
control, telecommunications and life sciences. Our products include
glass substrates for LCD televisions, computer monitors and laptops;
ceramic substrates and filters for mobile emission control systems;
optical fiber, cable, hardware & equipment for telecommunications
networks; optical biosensors for drug discovery; and other advanced
optics and specialty glass solutions for a number of industries
including semiconductor, aerospace, defense, astronomy and metrology.
SOURCE: Corning Incorporated
Corning Incorporated Pamela Strollo, 607-974-8375 strollopf@corning.com or M. Elizabeth Dann, 607-974-4989 dannme@corning.com
Copyright Business Wire 2008



